Form 8-K - Current report:
SEC Accession No. 0001136261-20-000007
Filing Date
2020-01-03
Accepted
2020-01-03 16:33:33
Documents
4
Period of Report
2020-01-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K body8k.htm 8-K 14021
2 OPINION exh5-1.htm EX-5.1 8484
3 STOCK PURCHASE AGREEMENT, DATED AS OF JANUARY 2, 2020, BY AND BETWEEN SEELOS THE exh10-1.htm EX-10.1 20490
4 LOGO image4055.jpg GRAPHIC 64418
  Complete submission text file 0001136261-20-000007.txt   133127
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 20506013
SIC: 2834 Pharmaceutical Preparations